Endothelial Cell-Specific Molecule-1 in Critically Ill Patients With Hematologic Malignancy.

Objectives: To assess whether serum concentration of endothelial cell-specific molecule-1 (Endocan) at ICU admission is associated with the use of ICU resources and outcomes in critically ill hematology patients.

Design: Prospective multicenter cohort study.

Setting: Seventeen ICUs in France and Belgium.